Southwest Oncology Group Study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: the importance of survival as a clinical trial end point. [electronic resource]
Producer: 20000727Description: 2537-44 p. digitalISSN:- 0732-183X
- Adult
- Aged
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carboplatin -- administration & dosage
- Carcinoma, Transitional Cell -- drug therapy
- Female
- Humans
- Male
- Middle Aged
- Paclitaxel -- administration & dosage
- Survival Rate
- Urologic Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.